Royal Bank Of Canada Aquestive Therapeutics, Inc. Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
A detailed history of Royal Bank Of Canada transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 10,325 shares of AQST stock, worth $31,491. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,325
Previous 6,985
47.82%
Holding current value
$31,491
Previous $18,000
183.33%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AQST
# of Institutions
121Shares Held
46.7MCall Options Held
517KPut Options Held
207K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$29.9 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$16.9 Million2.87% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$16.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.26MShares$13 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.77MShares$8.44 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $163M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...